CRISPR Therapeutics is a biopharmaceutical company that develops gene-based medicines using gene editing technology. Its work focuses on treatments for serious diseases, including blood disorders such as sickle cell disease and beta thalassemia, along with programs in immuno-oncology and regenerative medicine. The company carries out research and development aimed at correcting genetic causes of disease, and it works with partners on some of its programs. It is based in Zug, Switzerland, and also has research operations in the United States.
CRISPR Therapeutics AG is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code C2RS34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1184 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendWeak
39/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-7.0%
From 52-week high-36.4%
MomentumWeak
34/100
Lagging most stocks on this exchange.
See the numbers →
3-month return2.5%
6-month return-9.1%
12-month, skipping last month-20.6%
Stability (higher is calmer)Weak
32/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)52.9%
Worst drawdown, 1 year (smaller is calmer)-39.3%
LiquidityWeak
17/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M BRL
Zero-volume days40.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 29.91 – 49.75Daily closes, split-adjusted
Signals
50-day average34.95
200-day average33.69
Golden/death cross (60d)Golden, 20 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.54
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
32.27
Bearish
EMA 10
32.30
Bearish
SMA 20
33.61
Bearish
EMA 20
33.18
Bearish
SMA 50
34.95
Bearish
EMA 50
33.99
Bearish
SMA 100
34.15
Bearish
EMA 100
34.04
Bearish
SMA 200
33.69
Bearish
EMA 200
34.22
Bearish
Oscillators (daily)
RSI (14)
31.06
Neutral
MACD (12, 26)
-0.98
Bearish
Momentum (12)
-11.02
Bearish
Stochastic %K (14)
6.51
Bullish
Williams %R (14)
-93.49
Bullish
CCI (20)
-109.2
Bullish
Pivot points (classic, last session)
S3
30.04
S2
30.55
S1
30.93
Pivot
31.44
R1
31.82
R2
32.33
R3
32.71
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
